APA (7th ed.) Citation

Barbier-Torres, L., Fortner, K. A., Iruzubieta, P., Delgado, T. C., Giddings, E., Chen, Y., . . . Rincón, M. (2020). Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nature communications, 11(1), 3360-15. https://doi.org/10.1038/s41467-020-16991-2

Chicago Style (17th ed.) Citation

Barbier-Torres, Lucía, et al. "Silencing Hepatic MCJ Attenuates Non-alcoholic Fatty Liver Disease (NAFLD) by Increasing Mitochondrial Fatty Acid Oxidation." Nature Communications 11, no. 1 (2020): 3360-15. https://doi.org/10.1038/s41467-020-16991-2.

MLA (9th ed.) Citation

Barbier-Torres, Lucía, et al. "Silencing Hepatic MCJ Attenuates Non-alcoholic Fatty Liver Disease (NAFLD) by Increasing Mitochondrial Fatty Acid Oxidation." Nature Communications, vol. 11, no. 1, 2020, pp. 3360-15, https://doi.org/10.1038/s41467-020-16991-2.